January 14, 2003

pca policy

tips & tools

research update clinical trials up-to-date donate

  • Timely Testing, Great Care Turn Scary Experience into Positive One
    Michael Braude, a writer for the Kansas City Business Journal, discusses his prostate cancer, which was detected through an annual PSA screening. Business Journal, January 10.
  • Government Science Advisory Committees
    More than 200 science advisory boards provide advice to agencies of the government's Department of Health and Human Services on various topics. Some critics claim the Bush Administration staffs these advisory boards based on ideology, not science. Listen to experts discuss the issue on "Science Friday."
  • Prostate Pointers Treatment Injury Database
    Prostate Pointers has created a database where survivors may enter the side effects (impotence, incontinence, etc.) they experienced from their primary treatment. Men making treatment decisions may browse the results to help them assess the risks of each treatment.
  • African American Survivors Sought
    The “Find The Cause Campaign,” launched by the National Physician and Family Referral (NPFR) Project, will recruit 100 African American families as part of ongoing hereditary research. More African American men are diagnosed with prostate cancer than any other group of men in the world, and recent studies indicate it may run in their families. NPFR is working in partnership with 50 Hoops and the National Human Genome Center at Howard University to qualify families for the hereditary study. If you are African American and you or members of your family have been diagnosed with prostate cancer, please call the toll-free hotline at (800) 677-8441, or visit http://www.npfr.resourcez.com/.  
  • Toxic Mushroom Grows to Cancer-Fighting Status
    A chemical derived from the toxic jack-o'-lantern mushroom, irofulven, is being tested as a possible therapy for difficult-to-treat cancers, such as advanced ovarian, prostate, breast, liver, gastrointestinal and brain cancers. Early studies suggest irofulven may be even more potent when used in combination with such standard chemotherapies as cisplatin and taxotere. Miami Herald, January 9.
  • Red Clover Mimics Asian Diet for Prostate Health
    A study at Monash University in Victoria, Australia, has found that a supplement derived from red clover causes early-stage prostate cancer cells to die in numbers five-times greater than in an untreated control group. Newswise, January 9.
  • Interest Grows in Avocado Oil's Potential Benefits
    High in natural chemicals that lower cholesterol and fight disease, avocado oil is increasingly touted as even more healthy than olive or canola oil. Like the fruit, the oil has antioxidants such as Vitamin E, believed to reduce coronary artery disease and help the skin; lutein, a carotenoid that protects the eyes against diseases like cataracts and macular degeneration and that may guard against prostate cancer; and glutathione, which regulates other antioxidants, such as vitamins C and E. Chicago Tribune, January 8.
  • Prostate Specific Antigen-Related Variables Help Predict Prognosis In Relapsed Prostate Cancer
    The shorter the time to the first relapse of prostate cancer and to doubling of prostate specific antigen (PSA) at relapse, the poorer the prognosis, say researchers at the department of urology, Ashikaga Red Cross Hospital in Japan. DGReview, January 10.
  • Viagra Deaths Explained by New Understanding of Platelet Clumping
    Incidents of heart attack and stroke, some fatal, in a small number of men taking the drug Viagra were a mystery, as Viagra was originally developed to prevent these conditions -- not only by dilating blood vessels but also by stopping platelets in the blood from clumping. However, researchers at the University of Illinois Chicago College of Medicine claim the drug does just the opposite. Viagra, by elevating levels of a compound in cells called cyclic guanosine monophosphate, or cGMP, actually encourages platelets to aggregate. Acurian, January 9.
  • DNA Snippet Key to Cell Aging
    Researchers at the Boston University School of Medicine have found that a tiny snippet of DNA may be the link between the way cells fight cancer and their normal response to aging, a new study shows. Overall, the study suggests the process by which cells age--and eventually commit suicide--is actually a cancer prevention strategy, according to a report published in the Proceedings of the National Academy of Sciences. Reuters Health, January 10.
  • "Men are wise in proportion, not to their experience, but to their capacity for experience." - James Boswell, Life of Samuel Johnson, 1791

If you like aware please forward it to your friends.  Better yet, ask your friends to subscribe so that they can keep up-to-date on the latest in prostate cancer advocacy, outreach, awareness and news.

aware is produced by the National Prostate Cancer Coalition.  This publication seeks to inform and educate men and women about prostate cancer.  Information presented in this free publication does not necessarily represent the official position of NPCC.  Moreover, information for aware is culled from diverse web sites and information sources.  NPCC cannot guarantee the accuracy of these sources.  Due to the timeliness of the information, some links will change and/or deactivate without notice.

Publication Staff:
Press Secretary: Jamie Bearse
Editor:  Kathy Meade
Communications Consultant: Flo McAfee
Program Assistant: Holly Campbell

National Prostate Cancer Coalition
1154 15th Street, NW
Washington, DC 20005
202-463-9455
888-245-9455 (toll-free)
202-463-9456 (fax)
http://www.pcacoalition.org/